Concentrics Posts Comments on FDA Draft Guidance

Posted September 16th, 2014. Filed under Concentrics News

Concentrics Research has submitted feedback on the FDA draft guidance, “Best Practices in Developing Proprietary Names for Drugs,” released on May 29, 2014.  Concentrics Research has also participated in the task force that worked with the Consumer Healthcare Products Association (CHPA) to provide proposed changes to this guidance.  Concentrics supports CHPA’s position.

 

To request a copy of our response, complete the contact form at the bottom of this page.